S&P 500   0.66 (+14.63%)
DOW   0.66 (+14.63%)
QQQ   265.19 (-1.89%)
AAPL   437.50 (-2.97%)
MSFT   203.38 (-2.34%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   434.00 (-2.82%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,374.39 (-3.11%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   466.93 (-3.40%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
S&P 500   0.66 (+14.63%)
DOW   0.66 (+14.63%)
QQQ   265.19 (-1.89%)
AAPL   437.50 (-2.97%)
MSFT   203.38 (-2.34%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   434.00 (-2.82%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,374.39 (-3.11%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   466.93 (-3.40%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
S&P 500   0.66 (+14.63%)
DOW   0.66 (+14.63%)
QQQ   265.19 (-1.89%)
AAPL   437.50 (-2.97%)
MSFT   203.38 (-2.34%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   434.00 (-2.82%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,374.39 (-3.11%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   466.93 (-3.40%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
S&P 500   0.66 (+14.63%)
DOW   0.66 (+14.63%)
QQQ   265.19 (-1.89%)
AAPL   437.50 (-2.97%)
MSFT   203.38 (-2.34%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   434.00 (-2.82%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,374.39 (-3.11%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   466.93 (-3.40%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
Log in

NYSE:IVCInvacare Stock Price, Forecast & News

$7.13
-0.11 (-1.52 %)
(As of 08/11/2020 04:00 PM ET)
Add
Compare
Today's Range
$7.11
Now: $7.13
$7.33
50-Day Range
$5.95
MA: $6.68
$7.39
52-Week Range
$3.90
Now: $7.13
$11.63
Volume183,843 shs
Average Volume421,382 shs
Market Capitalization$245.45 million
P/E RatioN/A
Dividend Yield0.69%
Beta1.22
Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company operates through Europe, North America/Home Medical Equipment, Institutional Products Group, and the Asia/Pacific segments. It offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare, Invacare Top End, and Küschall brand names; and seating and positioning products. The company also provides lifestyle products, including pressure relieving overlays and mattress systems under the Invacare Softform and microAIR brands; safe resident handling products; residential care and home beds and bed accessories, and manual wheelchairs under the Invacare brand name; and personal care products. In addition, the company offers respiratory therapy products comprising stationary oxygen concentrators under the Platinum and Perfecto2 brands; portable oxygen concentrators; and Invacare HomeFill oxygen systems. Further, it sells and distributes healthcare furnishings consisting of long-term care beds, case goods, safe patient handling equipment, and other equipment and accessories for long-term care customers. It sells its products primarily to home medical equipment providers through retail and e-commerce channels, as well as to residential care operators, distributors, and government health service customers through its sales force, independent manufacturers' representatives, and distributors. Invacare Corporation was founded in 1885 and is headquartered in Elyria, Ohio.
Read More
Invacare logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.41 out of 5 stars


Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP46120310
Phone440-329-6000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$927.96 million
Cash Flow$0.10 per share
Book Value$8.20 per share

Profitability

Net Income$-53,330,000.00

Miscellaneous

Employees3,900
Market Cap$245.45 million
Next Earnings Date11/4/2020 (Estimated)
OptionableOptionable
$7.13
-0.11 (-1.52 %)
(As of 08/11/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive IVC News and Ratings via Email

Sign-up to receive the latest news and ratings for IVC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Invacare (NYSE:IVC) Frequently Asked Questions

How has Invacare's stock been impacted by COVID-19 (Coronavirus)?

Invacare's stock was trading at $6.05 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, IVC stock has increased by 17.9% and is now trading at $7.13.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Invacare?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Invacare in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Invacare
.

When is Invacare's next earnings date?

Invacare is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Invacare
.

How were Invacare's earnings last quarter?

Invacare Co. (NYSE:IVC) posted its quarterly earnings data on Wednesday, August, 5th. The health services provider reported ($0.21) EPS for the quarter, topping the consensus estimate of ($0.27) by $0.06. The health services provider had revenue of $196.30 million for the quarter, compared to the consensus estimate of $196 million. Invacare had a negative net margin of 4.82% and a negative return on equity of 9.36%. During the same period last year, the company posted ($0.31) EPS.
View Invacare's earnings history
.

How often does Invacare pay dividends? What is the dividend yield for Invacare?

Invacare declared a quarterly dividend on Thursday, February 20th. Shareholders of record on Friday, April 3rd will be given a dividend of $0.0125 per share on Friday, April 17th. This represents a $0.05 annualized dividend and a yield of 0.70%. The ex-dividend date is Thursday, April 2nd.
View Invacare's dividend history
.

What guidance has Invacare issued on next quarter's earnings?

Invacare issued an update on its FY 2020 After-Hours earnings guidance on Wednesday, August, 5th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $810-840 million, compared to the consensus revenue estimate of $897.99 million.

What price target have analysts set for IVC?

2 brokers have issued 12 month price targets for Invacare's stock. Their forecasts range from $11.00 to $17.00. On average, they anticipate Invacare's stock price to reach $14.00 in the next year. This suggests a possible upside of 96.4% from the stock's current price.
View analysts' price targets for Invacare
.

Has Invacare been receiving favorable news coverage?

Media coverage about IVC stock has trended negative this week, InfoTrie Sentiment reports. The research firm rates the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Invacare earned a news impact score of -2.1 on InfoTrie's scale. They also assigned press coverage about the health services provider a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the near future.
View the latest news about Invacare
.

Are investors shorting Invacare?

Invacare saw a increase in short interest during the month of July. As of July 31st, there was short interest totaling 4,750,000 shares, an increase of 6.5% from the July 15th total of 4,460,000 shares. Based on an average daily volume of 392,900 shares, the days-to-cover ratio is currently 12.1 days. Currently, 14.5% of the shares of the stock are short sold.
View Invacare's Short Interest
.

Who are some of Invacare's key competitors?

What other stocks do shareholders of Invacare own?

Who are Invacare's key executives?

Invacare's management team includes the following people:
  • Mr. Matthew E. Monaghan, Chairman, Pres & CEO (Age 51)
  • Ms. Kathleen P. Leneghan, Sr. VP & CFO (Age 56)
  • Mr. Anthony C. LaPlaca, Sr. VP, Gen. Counsel & Sec. (Age 61)
  • Ms. Darcie L. Karol, Sr. VP of HR (Age 52)
  • Mr. Ralf A. Ledda, Sr. VP & GM of EMEA (Age 51)

What is Invacare's stock symbol?

Invacare trades on the New York Stock Exchange (NYSE) under the ticker symbol "IVC."

Who are Invacare's major shareholders?

Invacare's stock is owned by a number of institutional and retail investors. Top institutional investors include Russell Investments Group Ltd. (3.36%), Paradigm Capital Management Inc. NY (2.30%), Principal Financial Group Inc. (0.81%), WINTON GROUP Ltd (0.54%), Wedge Capital Management L L P NC (0.49%) and Monarch Partners Asset Management LLC (0.31%). Company insiders that own Invacare stock include Clifford D Nastas, Kathleen P Leneghan and Matthew E Monaghan.
View institutional ownership trends for Invacare
.

Which major investors are selling Invacare stock?

IVC stock was sold by a variety of institutional investors in the last quarter, including Trexquant Investment LP, and UBS Group AG.
View insider buying and selling activity for Invacare
.

Which major investors are buying Invacare stock?

IVC stock was purchased by a variety of institutional investors in the last quarter, including Paradigm Capital Management Inc. NY, Russell Investments Group Ltd., Wedge Capital Management L L P NC, WINTON GROUP Ltd, Monarch Partners Asset Management LLC, Eqis Capital Management Inc., Principal Financial Group Inc., and Emerald Advisers LLC. Company insiders that have bought Invacare stock in the last two years include Clifford D Nastas, Kathleen P Leneghan, and Matthew E Monaghan.
View insider buying and selling activity for Invacare
.

How do I buy shares of Invacare?

Shares of IVC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Invacare's stock price today?

One share of IVC stock can currently be purchased for approximately $7.13.

How big of a company is Invacare?

Invacare has a market capitalization of $245.45 million and generates $927.96 million in revenue each year. The health services provider earns $-53,330,000.00 in net income (profit) each year or ($1.06) on an earnings per share basis. Invacare employs 3,900 workers across the globe.

What is Invacare's official website?

The official website for Invacare is www.invacare.com.

How can I contact Invacare?

Invacare's mailing address is ONE INVACARE WAY, ELYRIA OH, 44035. The health services provider can be reached via phone at 440-329-6000 or via email at [email protected]

This page was last updated on 8/11/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.